Article Details
Retrieved on: 2022-12-24 13:45:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Basel: Roche has announced that the U.S. Food and Drug Administration (USFDA) has approved Lunsumio (mosunetuzumab-axgb) for the treatment of ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here